SMARCA2 and cancer: In their computational meta‐analysis, Jose et al61 demonstrated that high SMARCA4 expression was associated with aggressive tumours, while high SMARCA2 expression was related to benign differentiated tumours, suggesting that SMARCA4 and SMARCA2 play opposite roles in cancers, including HCC.